Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Gligorov

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Expert Review of Anticancer Therapy|August 23, 2005
Docetaxel in the treatment of breast cancer: current experience and future prospectsJean-Marc Nabholtz, Joseph Gligorov
Women'S Health (London, England)|October 7, 2009
Taxane therapy for early stage breast cancerJean-Marc Nabholtz, Joseph Gligorov
Expert Opinion on Pharmacotherapy|June 17, 2005
The role of taxanes in the treatment of breast cancerJean-Marc Nabholtz, Joseph Gligorov
Drug Safety|September 2, 2006
Cardiovascular safety profiles of aromatase inhibitors : a comparative reviewJean-Marc Nabholtz, Joseph Gligorov
Current Opinion in Oncology|October 7, 2017
New anti-HER2 agents: from second-generation tyrosine kinases inhibitors to bifunctional antibodiesJoseph Gligorov, Sandrine Richard, Vladimir Todorovic
Nature Reviews. Clinical Oncology|October 17, 2022
Systemic therapy for early-stage breast cancer: learning from the past to build the futureElisa Agostinetto, Joseph Gligorov, Martine Piccart
Breast (Edinburgh, Scotland)|December 7, 2007
Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasisJoseph Gligorov, Kathleen Pritchard, Paul Goss
Chinese Clinical Oncology|January 9, 2018
Emilia: use cunning to survive cancerJoseph Gligorov, Sandrine Richard, Xavier Pivot
European Journal of Breast Health|July 14, 2020
Breast Cancer Management during the COVID 19 Pandemic: French GuidelinesEmile Daraï, Carole Mathelin, Joseph Gligorov
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Castration-dependent pharmacokinetics of docetaxel: do sex and/or ABCB1 polymorphism also matter?Joseph Gligorov, Anne Fajac, Jean-François Bernaudin
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Expert Review of Anticancer Therapy|August 23, 2005
Docetaxel in the treatment of breast cancer: current experience and future prospectsJean-Marc Nabholtz, Joseph Gligorov
Women'S Health (London, England)|October 7, 2009
Taxane therapy for early stage breast cancerJean-Marc Nabholtz, Joseph Gligorov
Expert Opinion on Pharmacotherapy|June 17, 2005
The role of taxanes in the treatment of breast cancerJean-Marc Nabholtz, Joseph Gligorov
Drug Safety|September 2, 2006
Cardiovascular safety profiles of aromatase inhibitors : a comparative reviewJean-Marc Nabholtz, Joseph Gligorov
Current Opinion in Oncology|October 7, 2017
New anti-HER2 agents: from second-generation tyrosine kinases inhibitors to bifunctional antibodiesJoseph Gligorov, Sandrine Richard, Vladimir Todorovic
Nature Reviews. Clinical Oncology|October 17, 2022
Systemic therapy for early-stage breast cancer: learning from the past to build the futureElisa Agostinetto, Joseph Gligorov, Martine Piccart
Breast (Edinburgh, Scotland)|December 7, 2007
Adjuvant and extended adjuvant use of aromatase inhibitors: reducing the risk of recurrence and distant metastasisJoseph Gligorov, Kathleen Pritchard, Paul Goss
Chinese Clinical Oncology|January 9, 2018
Emilia: use cunning to survive cancerJoseph Gligorov, Sandrine Richard, Xavier Pivot
European Journal of Breast Health|July 14, 2020
Breast Cancer Management during the COVID 19 Pandemic: French GuidelinesEmile Daraï, Carole Mathelin, Joseph Gligorov
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Castration-dependent pharmacokinetics of docetaxel: do sex and/or ABCB1 polymorphism also matter?Joseph Gligorov, Anne Fajac, Jean-François Bernaudin
Pageof 19